Description
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
| Purity | ≥95% |
|---|---|
| Formula | C138H230N46O34S4 |
| Formula Wt. | 3205.89 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hongbiao W, Baolong N, Mengkui X, et al. Biological activities of cecropin B-thanatin hybrid peptides. J Pept Res. 2005 Dec;66(6):382-6. PMID: 16316454.
σ1 antagonist.
Anionic lipopeptide, alters cell membrane organ...
Endogenous RF-amide peptide, involved in nocice...
Non-depolarizing NMJ blocker; nAChR antagonist....
c-MET, Tie-2, VEGFR inhibitor.
Peptide, bee venom toxin; SK2/3/4 K+ channel bl...
PLK1 inhibitor.
Nucleoside (adenosine) analog; viral DNA polyme...
Fungistatic
Synthetic steroid hormone, estrogen analog, use...
PI3K and mTOR inhibitor.
Found in Salvia; fatty acid synthase and AChE i...
Inhibitor of PTEFb/CDK9.
Fermentation impurity
Nucleoside (cytidine) analog; RT and telomerase...
pan-PI3K inhibitor.
Quinazoline; α1-adrenergic antagonist.
FAAH inhibitor.
Trichothecene mycotoxin produced by Fusarium.
Chalcone; SIRT activator, GABA-A positive modul...